MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 126 filers reported holding MACROGENICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,579 | -42.2% | 13,429 | -33.7% | 0.00% | – |
Q2 2023 | $108,311 | -32.6% | 20,245 | -9.7% | 0.00% | – |
Q1 2023 | $160,694 | -1.5% | 22,412 | -7.8% | 0.00% | – |
Q4 2022 | $163,187 | -18.8% | 24,320 | -58.1% | 0.00% | – |
Q3 2022 | $201,000 | +16.2% | 58,104 | -1.1% | 0.00% | – |
Q2 2022 | $173,000 | -71.1% | 58,752 | -13.4% | 0.00% | -100.0% |
Q1 2022 | $598,000 | -49.8% | 67,839 | -8.6% | 0.00% | 0.0% |
Q4 2021 | $1,192,000 | -20.6% | 74,252 | +3.6% | 0.00% | -50.0% |
Q3 2021 | $1,501,000 | -31.3% | 71,677 | -11.9% | 0.00% | -33.3% |
Q2 2021 | $2,185,000 | -17.0% | 81,335 | -1.6% | 0.00% | 0.0% |
Q1 2021 | $2,633,000 | +38.9% | 82,682 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $1,896,000 | -5.8% | 82,931 | +3.8% | 0.00% | 0.0% |
Q3 2020 | $2,013,000 | -0.9% | 79,898 | +9.8% | 0.00% | -25.0% |
Q2 2020 | $2,032,000 | +385.0% | 72,785 | +1.1% | 0.00% | +300.0% |
Q1 2020 | $419,000 | -48.1% | 71,990 | -3.1% | 0.00% | 0.0% |
Q4 2019 | $808,000 | -14.8% | 74,273 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $948,000 | -23.9% | 74,273 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $1,245,000 | +14.5% | 73,386 | +21.4% | 0.00% | 0.0% |
Q1 2019 | $1,087,000 | +40.3% | 60,460 | -1.0% | 0.00% | 0.0% |
Q4 2018 | $775,000 | -39.7% | 61,043 | +1.8% | 0.00% | 0.0% |
Q3 2018 | $1,286,000 | +3.8% | 59,972 | -0.0% | 0.00% | -33.3% |
Q2 2018 | $1,239,000 | -4.5% | 59,994 | +16.3% | 0.00% | 0.0% |
Q1 2018 | $1,298,000 | +27.9% | 51,580 | -3.5% | 0.00% | +50.0% |
Q4 2017 | $1,015,000 | +1.3% | 53,439 | -1.4% | 0.00% | 0.0% |
Q3 2017 | $1,002,000 | -2.9% | 54,213 | -8.0% | 0.00% | 0.0% |
Q2 2017 | $1,032,000 | -11.6% | 58,949 | -6.1% | 0.00% | 0.0% |
Q1 2017 | $1,167,000 | -13.2% | 62,749 | -4.6% | 0.00% | -33.3% |
Q4 2016 | $1,344,000 | -33.4% | 65,749 | -2.5% | 0.00% | -25.0% |
Q3 2016 | $2,017,000 | +11.8% | 67,449 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $1,804,000 | +44.1% | 66,849 | +0.1% | 0.00% | +33.3% |
Q1 2016 | $1,252,000 | -30.8% | 66,754 | +14.3% | 0.00% | -25.0% |
Q4 2015 | $1,809,000 | +47.2% | 58,401 | +1.8% | 0.00% | +33.3% |
Q3 2015 | $1,229,000 | -37.0% | 57,363 | +11.7% | 0.00% | -40.0% |
Q2 2015 | $1,950,000 | +70.5% | 51,363 | +40.8% | 0.01% | +66.7% |
Q1 2015 | $1,144,000 | -58.3% | 36,467 | -53.4% | 0.00% | -50.0% |
Q4 2014 | $2,745,000 | +256.0% | 78,267 | +112.1% | 0.01% | +200.0% |
Q3 2014 | $771,000 | -2.8% | 36,909 | +1.1% | 0.00% | 0.0% |
Q2 2014 | $793,000 | +154.2% | 36,500 | +225.9% | 0.00% | +100.0% |
Q1 2014 | $312,000 | +9.5% | 11,200 | +7.7% | 0.00% | 0.0% |
Q4 2013 | $285,000 | – | 10,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $19,316,000 | 17.74% |
Rhenman & Partners Asset Management AB | 967,186 | $17,390,000 | 2.03% |
BB BIOTECH AG | 3,400,000 | $61,132,000 | 1.54% |
Hood River Capital Management LLC | 1,443,196 | $25,949,000 | 1.31% |
Sofinnova Investments, Inc. | 523,756 | $9,418,000 | 0.91% |
Prosight Management, LP | 107,560 | $1,934,000 | 0.85% |
683 Capital Management, LLC | 484,970 | $8,720,000 | 0.79% |
Bellevue Group AG | 790,305 | $14,210,000 | 0.78% |
Opus Point Partners Management, LLC | 30,075 | $541,000 | 0.73% |
Rubric Capital Management LP | 282,200 | $5,074,000 | 0.47% |